Purchases and Sales Made in Q4 2022 in Maia Biotechnology, Inc. (MAIA)
This table provides information about the institutional ownership of Maia Biotechnology, Inc. (MAIA) during Q4 2022. The information is specifically focused on institutions that hold shares of MAIA Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 07, 2023
Q4 2022
|
Lynwood Capital Management Inc.
|
BUY
|
- |
50.2K+ 25.13% |
$156K - $193K
|
250K
$553K
|
|
|
Jan 04, 2023
Q4 2022
|
Centric Wealth Management
|
BUY
|
- |
40.2KNew |
$125K - $155K
|
40.2K
$88.9K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
302+ 8.45% |
$936 - $1.16K
|
3.87K
$8.56K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
2New |
$6.2 - $7.7
|
2
$4.42
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.56K- 33.96% |
$4.83K - $6K
|
3.03K
$6.7K
|